Why the study?
Does cardiac-specific overexpression of Thioredoxin-1 (Trx1) improve postischemic ventricular and mitochondrial dysfunction in a mouse model of stunned myocardium?
Does cardiac-specific overexpression of Thioredoxin-1 (Trx1) improve postischemic ventricular and mitochondrial dysfunction in a mouse model of stunned myocardium?
Cardiac-specific overexpression of Thioredoxin-1 attenuates post-ischemic ventricular and mitochondrial dysfunction in a mouse model of stunned myocardium, suggesting a potential protective mechanism against ischemia/reperfusion injury.
Answers are grounded in this paper and cite their sources.
Trx1 overexpression attenuates reperfusion injury in mice; leaves open translation to human stunned myocardium.
AIM: We evaluated the effect of thioredoxin1 (Trx1) system on postischemic ventricular and mitochondrial dysfunction using transgenic mice overexpressing cardiac Trx1 and a dominant negative (DN-Trx1) mutant (C32S/C35S) of Trx1. Langendorff-perfused hearts were subjected to 15 min of ischemia followed by 30 min of reperfusion (R). We measured left ventricular developed pressure (LVDP, mmHg), left ventricular end diastolic pressure (LVEDP, mmHg), and t63 (relaxation index, msec). Mitochondrial respiration, SERCA2a, phospholamban (PLB), and phospholamban phosphorylation (p-PLB) Thr17 expression (Western blot) were also evaluated. RESULTS: At 30 min of reperfusion, Trx1 improved contractile state (LVDP: Trx1: 57.4 ± 4.9 vs. Wt: 27.1 ± 6.3 and DN-Trx1: 29.2 ± 7.1, p < 0.05); decreased myocardial stiffness (LVEDP: Wt: 24.5 ± 4.8 vs. Trx1: 11.8 ± 2.9, p < 0.05); and improved the isovolumic relaxation (t63: Wt: 63.3 ± 3.2 vs. Trx1: 51.4 ± 1.9, p < 0.05). DN-Trx1 mice aggravated the myocardial stiffness and isovolumic relaxation. Only the expression of p-PLB Thr17 increased at 1.5 min R in Wt and DN-Trx1 groups. At 30 min of reperfusion, state 3 mitochondrial O2 consumption was impaired by 13% in Wt and by 33% in DN-Trx1. ADP/O ratios for Wt and DN-Trx1 decrease by 25% and 28%, respectively; whereas the Trx1 does not change after ischemia and reperfusion (I/R). Interestingly, baseline values of complex I activity were increased in Trx1 mice; they were 24% and 47% higher than in Wt and DN-Trx1 mice, respectively (p < 0.01). INNOVATION AND CONCLUSION: These results strongly suggest that Trx1 ameliorates the myocardial effects of I/R by improving the free radical-mediated damage in cardiac and mitochondrial function, opening the possibility of new therapeutic strategies in coronary artery disease. Antioxid. Redox Signal. 25, 78-88.
No takes yet. Share an insight, caveat, or question.
Pérez et al. (2016) studied Stunned myocardium (post-ischemic ventricular and mitochondrial dysfunction). Cardiac-specific overexpression of Trx1 vs. Wild-type and DN-Trx1 mice was evaluated on Left ventricular developed pressure (LVDP) at 30 min of reperfusion (p=<0.05).
Synapse has enriched 10 related papers. Consider them for comparative context: